359 related articles for article (PubMed ID: 36185030)
1. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
Deng L; Yang Y; Xu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin attenuates liver fibrosis in high-fat diet/streptozotocin-induced mice by modulating gut microbiota.
Huang C; Qian J; Liu Y; Zhang L; Yang Y
Clin Exp Pharmacol Physiol; 2024 Mar; 51(3):e13842. PubMed ID: 38302074
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effects of empagliflozin and liraglutide on lipid metabolism and intestinal microflora in diabetic mice.
Yang Q; Deng L; Feng C; Wen J
PeerJ; 2024; 12():e17055. PubMed ID: 38500527
[TBL] [Abstract][Full Text] [Related]
5. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
[TBL] [Abstract][Full Text] [Related]
6. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
[TBL] [Abstract][Full Text] [Related]
7. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
[TBL] [Abstract][Full Text] [Related]
8. The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats.
An Y; Dai H; Duan Y; Cheng L; Shi L; He C; Wang C; Lv Y; Li H; Zhang H; Huang Y; Fu W; Sun W; Zhao B
Chin Med; 2023 May; 18(1):49. PubMed ID: 37147692
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
[TBL] [Abstract][Full Text] [Related]
10. Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy.
Luo L; Luo J; Cai Y; Fu M; Li W; Shi L; Liu J; Dong R; Xu X; Tu L; Yang Y
Pharmacol Res; 2022 Sep; 183():106367. PubMed ID: 35882293
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes.
Deng X; Zhang C; Wang P; Wei W; Shi X; Wang P; Yang J; Wang L; Tang S; Fang Y; Liu Y; Chen Y; Zhang Y; Yuan Q; Shang J; Kan Q; Yang H; Man H; Wang D; Yuan H
J Clin Endocrinol Metab; 2022 Jun; 107(7):1888-1896. PubMed ID: 35397165
[TBL] [Abstract][Full Text] [Related]
12. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
13. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
14. Analysis from the EMPA-REG OUTCOME
Mayer GJ; Wanner C; Weir MR; Inzucchi SE; Koitka-Weber A; Hantel S; von Eynatten M; Zinman B; Cherney DZI
Kidney Int; 2019 Aug; 96(2):489-504. PubMed ID: 31142441
[TBL] [Abstract][Full Text] [Related]
15. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.
Zhang XY; Chen J; Yi K; Peng L; Xie J; Gou X; Peng T; Tang L
Gut Microbes; 2020 Nov; 12(1):1-18. PubMed ID: 33222603
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota.
Lee YS; Lee D; Park GS; Ko SH; Park J; Lee YK; Kang J
Food Funct; 2021 Jul; 12(14):6363-6373. PubMed ID: 34105563
[TBL] [Abstract][Full Text] [Related]
17. Edgeworthia gardneri (Wall.) Meisn. water extract improves diabetes and modulates gut microbiota.
Zhang Z; Xu H; Zhao H; Geng Y; Ren Y; Guo L; Shi J; Xu Z
J Ethnopharmacol; 2019 Jul; 239():111854. PubMed ID: 30954614
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
[TBL] [Abstract][Full Text] [Related]
19. SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db/db mice.
Gong Q; Zhang R; Wei F; Fang J; Zhang J; Sun J; Sun Q; Wang H
Biomed Pharmacother; 2022 Aug; 152():113222. PubMed ID: 35671581
[TBL] [Abstract][Full Text] [Related]
20. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
Zhang L; Luo J; Li X; Guo S; Shi D
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
